Vascular Benefits of Adding CarvedilolCR to Type2 Diabetic Patients on ACEI.
Clinical trial NCT00430040 · TERMINATED
Trial details
- NCT number
- NCT00430040
- Sponsor
- University at Buffalo
- Status
- TERMINATED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2007-02-01
- Primary completion
- 2013-05-01
- Enrollment
- 14
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.